HIGHLIGHTS
- who: Carcinoma Growth and colleagues from the Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China have published the Article: NOL12 as an Oncogenic Biomarker Promotes Hepatocellular Carcinoma Growth and Metastasis, in the Journal: Oxidative Medicine and Cellular Longevity of 23/Nov/2021
- what: To date, this study shows for the first time the important role of NOL12 in the prognosis of HCC.
- how: The results indicated that NOL12 can act as a novel prognostic biomarker and a potential therapeutic target for HCC. The results showed that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.